What is Brainstorm Cell Therapeutics Inc?
, a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company's NurOwn proprietary cell therapy platform that leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 11.92M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.